Download Free Sample
captcha refresh

Fluoroscopy and Mobile C-arms Market Size, Share, Growth, and Industry Analysis, By Type (Full-size C-arms,Mini C-arms), By Application (Hospitals,Clinics,Diagnostic Centers), Regional Insights and Forecast to 2035

Fluoroscopy and Mobile C-arms Market Overview

Global Fluoroscopy and Mobile C-arms Market size is estimated at USD 2759.42 million in 2026 and expected to rise to USD 3893.86 million by 2035, experiencing a CAGR of 3.9%.

The Fluoroscopy and Mobile C-arms Market is expanding due to the increasing demand for real-time diagnostic imaging used in over 65% of minimally invasive surgical procedures worldwide. Fluoroscopy systems enable continuous X-ray imaging at frame rates between 7.5 frames per second and 30 frames per second, supporting surgical guidance across cardiology, orthopedics, urology, and gastrointestinal procedures. Hospitals account for approximately 70% of installed fluoroscopy systems globally, while mobile C-arms represent nearly 45% of intraoperative imaging equipment used in operating rooms. More than 310 million diagnostic imaging procedures are conducted globally each year using fluoroscopic imaging technologies. Around 28 million orthopedic procedures annually rely on mobile C-arm imaging systems to visualize bone alignment, implant placement, and fracture fixation. Fluoroscopy devices operate with radiation dose ranges between 2 mGy and 60 mGy depending on the imaging protocol and clinical application.

Mobile C-arms are widely used because of their flexibility, with device rotation angles reaching up to 135 degrees and detector sizes ranging from 20 cm to 30 cm. Over 60% of hospitals in developed countries utilize digital flat-panel detector C-arms rather than image intensifier systems due to improved resolution exceeding 3 megapixels. The Fluoroscopy and Mobile C-arms Market Report highlights that more than 1.2 million fluoroscopy-guided interventions are performed monthly across major healthcare facilities worldwide. The Fluoroscopy and Mobile C-arms Market Analysis also indicates that portable systems weigh between 250 kg and 450 kg, enabling mobility across surgical suites and emergency departments. Approximately 52% of hospitals globally operate at least two mobile C-arm units within orthopedic or trauma operating rooms. The Fluoroscopy and Mobile C-arms Industry Report shows that technological advancements such as AI-assisted image processing and 3D imaging reconstruction are integrated into nearly 38% of newly installed systems, improving surgical visualization accuracy by up to 30%.

The United States represents one of the largest markets for fluoroscopy and mobile C-arms, supported by more than 6,100 hospitals and approximately 10,000 ambulatory surgical centers performing fluoroscopy-guided procedures. Around 90 million imaging procedures annually involve X-ray fluoroscopy technologies in the country. The Fluoroscopy and Mobile C-arms Market Research Report shows that nearly 72% of operating rooms in large U.S. hospitals are equipped with at least one mobile C-arm system. Orthopedic surgeries in the United States exceed 7 million annually, and over 60% of fracture fixation procedures utilize C-arm imaging guidance. More than 1.5 million spinal surgeries performed each year rely on fluoroscopic imaging to guide implant placement and instrumentation. In interventional cardiology, approximately 1.2 million angioplasty procedures annually require fluoroscopic visualization.

Digital flat-panel detectors are used in approximately 68% of fluoroscopy systems installed in U.S. healthcare facilities. These detectors deliver spatial resolution exceeding 2.5 line pairs per millimeter, improving visualization of vascular structures and orthopedic implants. Around 48% of mobile C-arms installed after 2020 incorporate 3D imaging capability and advanced image processing software. Radiation safety standards in the United States require fluoroscopy devices to maintain exposure levels below 50 mGy per minute during standard procedures. More than 85% of new systems incorporate dose monitoring technologies that reduce radiation exposure by nearly 35%. The Fluoroscopy and Mobile C-arms Market Size in the United States continues to expand as healthcare facilities perform more than 40 million minimally invasive procedures annually requiring real-time imaging support.

Global Fluoroscopy and Mobile C-arms Market Size,

Key Findings

  • Key Market Driver: Approximately 64% minimally invasive surgeries utilize fluoroscopy while 58% orthopedic procedures require mobile C-arms globally
  • Major Market Restraint: Nearly 41% healthcare professionals report radiation exposure concerns while 36% hospitals enforce strict imaging safety protocols
  • Emerging Trends: Around 67% new systems adopt flat panel detectors while 39% integrate artificial intelligence imaging technologies
  • Regional Leadership: North America holds 38% installations while Europe accounts 29% and Asia Pacific contributes 24% systems
  • Competitive Landscape: Top 5 manufacturers control 63% global installations while leading companies supply systems across 120 countries
  • Market Segmentation: Full size C-arms represent 62% installations while mini C-arms account 38% orthopedic imaging procedures
  • Recent Development: Nearly 44% newly launched systems integrate 3D imaging while 33% adopt automated positioning technologies

The Fluoroscopy and Mobile C-arms Market Trends are increasingly shaped by the rapid adoption of digital flat-panel detector technology, which accounts for nearly 67% of newly installed fluoroscopy systems worldwide. Flat-panel detectors provide image resolution exceeding 3 megapixels and enable high-contrast imaging necessary for interventional cardiology and orthopedic procedures. Hospitals using digital fluoroscopy equipment report approximately 28% improvement in surgical visualization accuracy compared with traditional image intensifier technology. Another key Fluoroscopy and Mobile C-arms Market Trend involves the integration of three-dimensional imaging capabilities into mobile C-arm systems. Approximately 42% of newly launched systems support 3D cone-beam CT imaging, which allows surgeons to visualize anatomical structures from multiple angles during procedures. These systems generate more than 500 reconstructed images per scan cycle, improving surgical precision during spinal instrumentation and trauma surgeries.

Artificial intelligence-based image processing algorithms are also becoming common within the Fluoroscopy and Mobile C-arms Industry Analysis. Nearly 39% of systems released after 2022 include AI-based noise reduction and automated image enhancement features that improve clarity while reducing radiation exposure by nearly 30%. These algorithms analyze imaging data in less than 0.5 seconds, enabling real-time decision-making during surgical interventions. The increasing use of minimally invasive procedures significantly contributes to Fluoroscopy and Mobile C-arms Market Growth. More than 72% of vascular interventions and approximately 58% of orthopedic fixation procedures rely on fluoroscopy guidance. Healthcare facilities performing minimally invasive procedures have increased operating room utilization rates by nearly 40% due to shorter patient recovery times and improved surgical outcomes.

Fluoroscopy and Mobile C-arms Market Dynamics

DRIVER

"Rising demand for minimally invasive surgical procedures"

More than 320 million surgical procedures are performed worldwide annually, and approximately 64% of these procedures are now conducted using minimally invasive techniques requiring fluoroscopic imaging. Mobile C-arm systems support real-time visualization during orthopedic trauma surgeries, spinal procedures, and cardiovascular interventions. Around 58% of orthopedic fracture fixation procedures depend on intraoperative fluoroscopy to guide implant placement and alignment. Interventional cardiology procedures exceed 8 million annually, and nearly 90% of angioplasty operations require fluoroscopy guidance. Hospitals performing minimally invasive surgeries report up to 40% shorter patient recovery times and 25% reduction in postoperative complications. These clinical benefits have led more than 70% of tertiary hospitals to install advanced fluoroscopy imaging systems within operating rooms and interventional suites.

RESTRAINT

"High radiation exposure concerns during imaging procedures"

Radiation exposure associated with fluoroscopy imaging remains a significant concern for healthcare professionals and regulatory agencies. Standard fluoroscopic procedures generate radiation doses ranging from 5 mGy to 60 mGy depending on the imaging duration and clinical application. Studies indicate that approximately 41% of healthcare professionals working with fluoroscopy systems experience cumulative radiation exposure risks during long surgical procedures. Regulatory authorities in more than 50 countries enforce strict safety guidelines limiting fluoroscopy exposure levels to protect patients and medical staff. Nearly 36% of hospitals have implemented additional radiation monitoring protocols requiring specialized protective equipment such as lead aprons and shielding barriers. These safety requirements increase operational complexity and sometimes limit the use of fluoroscopic imaging during routine diagnostic procedures.

OPPORTUNITY

"Expansion of outpatient surgical centers and ambulatory imaging facilities"

Outpatient surgical centers are expanding rapidly worldwide, with more than 10,000 ambulatory surgical facilities operating across developed healthcare systems. Approximately 48% of minimally invasive procedures are now performed in outpatient environments rather than large hospitals. These facilities require compact mobile C-arm imaging systems capable of delivering high-resolution imaging within limited operating room space. Portable fluoroscopy systems weighing less than 350 kg have gained strong adoption across outpatient clinics due to their flexible positioning and simplified installation. Orthopedic procedures such as joint injections and fracture stabilization represent nearly 55% of procedures conducted in outpatient surgical centers using C-arm imaging. As a result, nearly 52% of newly installed fluoroscopy units globally are deployed in outpatient and specialty surgical centers.

CHALLENGE

"High equipment cost and maintenance complexity"

Advanced fluoroscopy systems involve complex imaging components including high-resolution detectors, X-ray generators, and digital imaging software platforms. A typical mobile C-arm contains more than 3,500 electronic components and requires routine calibration every 6 months to maintain imaging accuracy. Maintenance procedures include detector calibration, radiation dose verification, and software upgrades. Approximately 34% of healthcare facilities report operational challenges related to equipment servicing and maintenance downtime. In addition, installation of fluoroscopy systems requires radiation-shielded operating rooms with wall protection thickness exceeding 2 millimeters of lead equivalence. These infrastructure requirements increase installation complexity for smaller healthcare facilities. As a result, around 29% of diagnostic clinics continue using older imaging systems instead of upgrading to advanced digital fluoroscopy platforms.

Fluoroscopy and Mobile C-arms Market Segmentation

The Fluoroscopy and Mobile C-arms Market segmentation includes equipment types and clinical applications widely used across healthcare facilities. Full-size C-arms represent the majority of surgical imaging systems used in operating rooms, while mini C-arms are primarily deployed for orthopedic extremity imaging. Hospitals remain the largest users followed by clinics and diagnostic centers.

Global Fluoroscopy and Mobile C-arms Market Size, 2035

BY TYPE

Full-size C-arms: Full-size C-arms account for nearly 62% of global installations due to their advanced imaging capability and ability to support complex surgical procedures. These systems typically include flat-panel detectors measuring between 25 cm and 30 cm with imaging resolutions exceeding 3 megapixels. Full-size C-arms support more than 70% of interventional cardiology and vascular procedures requiring high-resolution imaging guidance. The systems allow rotation angles up to 135 degrees and generate real-time imaging at 30 frames per second. Around 68% of tertiary hospitals worldwide operate at least two full-size C-arm units within surgical theaters. Advanced models integrate 3D imaging functionality generating over 500 reconstructed images during a single scan cycle to support spinal and trauma surgeries.

Mini C-arms: Mini C-arms represent approximately 38% of the Fluoroscopy and Mobile C-arms Market Share and are primarily used for orthopedic extremity imaging. These systems typically weigh between 80 kg and 120 kg, making them significantly lighter than full-size units used in operating rooms. Mini C-arms support imaging for hand, wrist, foot, and ankle procedures which collectively account for more than 20 million orthopedic treatments annually. Image detectors in mini C-arms measure between 15 cm and 20 cm and produce spatial resolutions exceeding 2.2 line pairs per millimeter. Around 55% of orthopedic clinics globally utilize mini C-arms to assist fracture reduction and implant positioning. These systems also reduce radiation exposure by nearly 25% compared with conventional fluoroscopy units.

BY APPLICATION

Hospitals: Hospitals represent nearly 70% of the total Fluoroscopy and Mobile C-arms Market Size due to their large volume of surgical and interventional procedures. Large healthcare facilities perform over 200 surgical procedures daily, and approximately 60% of these operations require intraoperative imaging support. Hospitals operate multiple imaging suites equipped with fluoroscopy systems capable of delivering continuous X-ray imaging at frame rates up to 30 frames per second. Approximately 72% of tertiary hospitals worldwide maintain dedicated fluoroscopy units for cardiovascular, orthopedic, and gastrointestinal interventions. Hospitals also account for more than 65% of interventional cardiology procedures globally. Increasing patient admissions and surgical procedure volumes exceeding 320 million annually continue to drive hospital demand for advanced mobile C-arm systems.

Clinics: Medical clinics account for approximately 18% of the Fluoroscopy and Mobile C-arms Market installations, primarily supporting pain management, orthopedic treatments, and minor surgical procedures. Nearly 12 million outpatient orthopedic treatments are performed annually in clinics requiring fluoroscopic imaging for accurate diagnosis and treatment guidance. Clinics typically utilize compact mobile C-arms weighing between 250 kg and 350 kg for flexible movement across treatment rooms. Around 46% of pain management clinics use fluoroscopy guidance during spinal injections and nerve block procedures. Digital fluoroscopy technology improves imaging clarity by nearly 30% compared with analog systems, allowing physicians to accurately guide needles and implants during minimally invasive procedures conducted in outpatient settings.

Diagnostic Centers: Diagnostic centers represent nearly 12% of Fluoroscopy and Mobile C-arms Market utilization due to their focus on imaging-based diagnosis and interventional radiology procedures. Globally more than 15,000 diagnostic imaging centers provide fluoroscopy-guided procedures such as barium swallow examinations and gastrointestinal imaging studies. These facilities conduct approximately 20 million fluoroscopic diagnostic procedures annually. Digital fluoroscopy systems used in diagnostic centers typically operate with radiation exposure levels below 15 mGy per minute for routine examinations. Around 52% of diagnostic centers integrate fluoroscopy systems with digital PACS networks allowing radiologists to analyze imaging data within seconds. Increasing demand for early disease diagnosis continues to drive installation of advanced fluoroscopy imaging equipment in specialized diagnostic facilities.

Fluoroscopy and Mobile C-arms Market Regional Outlook

The Fluoroscopy and Mobile C-arms Market Outlook demonstrates strong regional adoption supported by increasing surgical volumes, expanding diagnostic imaging infrastructure, and rising orthopedic and cardiovascular procedures exceeding 350 million annually worldwide across hospitals, clinics, and ambulatory surgical centers requiring real-time fluoroscopic imaging technologies.

Global Fluoroscopy and Mobile C-arms Market Share, by Type 2035

NORTH AMERICA

North America accounts for approximately 38% of the Fluoroscopy and Mobile C-arms Market Share due to advanced healthcare infrastructure and high adoption of digital imaging systems. The region includes more than 7,200 hospitals and nearly 11,000 ambulatory surgical centers performing fluoroscopy-guided procedures. Around 72% of surgical suites in the United States and Canada utilize mobile C-arm systems for orthopedic trauma and cardiovascular procedures. Approximately 9 million interventional cardiology procedures annually depend on fluoroscopy imaging in North America. Digital flat-panel detector systems represent nearly 68% of installed fluoroscopy units across the region. Hospitals in North America perform more than 45 million minimally invasive procedures each year requiring intraoperative imaging support.

EUROPE

Europe represents nearly 29% of the global Fluoroscopy and Mobile C-arms Market Size, supported by advanced healthcare systems across more than 44 countries. The region operates approximately 15,000 hospitals and specialized medical centers conducting fluoroscopic imaging procedures. Nearly 63% of orthopedic surgeries in Europe rely on mobile C-arm guidance for fracture fixation and spinal procedures. More than 6 million cardiovascular interventions are performed annually across Germany, France, Italy, and the United Kingdom requiring real-time fluoroscopic imaging. Digital fluoroscopy technology accounts for approximately 61% of installed systems in European hospitals. Radiation safety guidelines across the European Union require fluoroscopy systems to maintain patient exposure levels below 20 mGy per minute in routine diagnostic imaging procedures.

ASIA-PACIFIC

Asia-Pacific accounts for nearly 24% of the Fluoroscopy and Mobile C-arms Market Share driven by rapidly expanding healthcare infrastructure across China, India, Japan, South Korea, and Southeast Asia. The region contains more than 25,000 hospitals performing surgical procedures requiring imaging guidance. Around 14 million orthopedic procedures annually depend on mobile C-arm systems across Asia-Pacific healthcare facilities. China alone operates over 34,000 hospitals and medical institutions with growing demand for digital fluoroscopy systems. Approximately 55% of new hospital imaging installations in Asia-Pacific involve mobile C-arm technology. Increasing prevalence of cardiovascular diseases affecting more than 150 million individuals across the region continues to drive adoption of fluoroscopy imaging systems.

MIDDLE EAST AND AFRICA

The Middle East and Africa account for approximately 9% of the Fluoroscopy and Mobile C-arms Market Size supported by growing healthcare investments and medical infrastructure expansion. More than 4,500 hospitals operate across the region performing fluoroscopy-based diagnostic and surgical procedures. Approximately 3 million orthopedic and trauma surgeries annually require mobile C-arm imaging support. Countries including Saudi Arabia, United Arab Emirates, and South Africa are expanding healthcare facilities, with nearly 40% of new hospital imaging equipment installations including fluoroscopy systems. Digital imaging technologies represent nearly 46% of installed systems across major hospitals in the region. Increasing medical tourism procedures exceeding 2 million annually also contribute to the demand for advanced imaging equipment.

List of Top Fluoroscopy and Mobile C-arms Companies

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Hitachi, Ltd
  • Shimadzu
  • Canon Medical Systems
  • Ziehm Imaging GmbH
  • Hologic
  • Orthoscan Inc
  • Allengers Medical Systems
  • EcoRay
  • Eurocolumbus
  • Italray
  • Omega Medical Imaging

Top Two Companies with the Highest Market Share

  • GE Healthcare holds approximately 21% global installation share with more than 40,000 fluoroscopy and C-arm imaging systems deployed across 120 countries.
  • Philips Healthcare accounts for nearly 18% global system installations supporting over 30 million fluoroscopy-guided procedures annually in hospitals and surgical centers.

Investment Analysis and Opportunities

The Fluoroscopy and Mobile C-arms Market Analysis reveals increasing investment activity driven by the growing number of surgical procedures and the need for advanced intraoperative imaging technologies. Globally more than 320 million surgical procedures are performed annually, and approximately 64% of these operations require imaging guidance technologies such as fluoroscopy or mobile C-arm systems. Healthcare infrastructure development across emerging economies is contributing to new imaging equipment investments in more than 18,000 hospitals undergoing modernization programs. Healthcare systems worldwide allocate nearly 10% to 12% of hospital capital equipment budgets toward diagnostic imaging technologies. Mobile C-arms represent approximately 27% of intraoperative imaging equipment purchased by surgical facilities. Orthopedic departments account for nearly 45% of hospital imaging equipment purchases because fracture fixation and spinal procedures require continuous real-time visualization during surgery.

Investments are also increasing in ambulatory surgical centers and outpatient facilities. Globally more than 10,000 ambulatory surgical centers perform minimally invasive procedures requiring mobile fluoroscopy imaging systems. These facilities conduct approximately 23 million outpatient surgical procedures each year. Nearly 52% of newly installed mobile C-arm systems are deployed in outpatient surgical environments due to their compact design and flexible positioning capabilities. Technology innovation is attracting substantial investment across imaging manufacturers developing digital fluoroscopy systems with improved resolution and radiation dose management. More than 60% of newly installed C-arm systems incorporate flat-panel detector technology capable of delivering image resolution exceeding 3 megapixels. Hospitals investing in digital imaging systems report approximately 30% improvement in surgical accuracy and 25% reduction in procedure duration.

New Product Development

New product development in the Fluoroscopy and Mobile C-arms Market focuses on advanced imaging resolution, radiation dose reduction technologies, and improved mobility for surgical environments. Modern digital fluoroscopy systems now integrate flat-panel detectors capable of producing image resolutions exceeding 3 megapixels with frame rates reaching 30 frames per second. These systems generate more than 500 reconstructed images during a single 3D scan cycle, improving surgical visualization for spinal and orthopedic procedures. Manufacturers are increasingly developing compact mobile C-arm systems designed for outpatient surgical centers and small clinics. These new-generation devices typically weigh between 250 kilograms and 350 kilograms and support rotation angles up to 135 degrees, allowing surgeons to capture multiple imaging perspectives during complex procedures. Approximately 48% of new fluoroscopy devices launched after 2022 include motorized positioning systems that allow automated device alignment within 10 seconds.

Artificial intelligence integration is becoming a key innovation within new fluoroscopy systems. Nearly 39% of newly developed imaging devices incorporate AI-powered image processing software capable of reducing image noise and enhancing anatomical structures during procedures. AI algorithms analyze imaging data within 0.5 seconds and automatically adjust exposure parameters to reduce radiation levels by approximately 30%. Radiation dose management technology is also a major focus of product innovation. More than 85% of newly launched fluoroscopy systems integrate automatic dose monitoring and exposure control features. These systems maintain radiation exposure levels below 20 mGy per minute during diagnostic procedures while maintaining high image clarity. Advanced filtration systems integrated into X-ray generators reduce unnecessary radiation exposure by nearly 35%.

Five Recent Developments

  • In 2023, GE Healthcare introduced an advanced mobile C-arm system equipped with flat-panel detector technology capable of producing images with resolution exceeding 3 megapixels and generating over 500 reconstructed images per scan cycle.
  • In 2023, Siemens Healthineers expanded its digital fluoroscopy portfolio with a system integrating automated radiation dose management capable of reducing patient exposure levels by approximately 30% during interventional procedures.
  • In 2024, Philips Healthcare launched a mobile C-arm platform integrating artificial intelligence image processing technology that analyzes fluoroscopy images in less than 0.5 seconds for improved surgical guidance.
  • In 2024, Ziehm Imaging introduced a 3D C-arm imaging system capable of generating more than 400 three-dimensional images per scan cycle for spinal and orthopedic surgical procedures.
  • In 2025, Canon Medical Systems released a digital fluoroscopy system with wireless connectivity enabling image transfer to hospital PACS networks within 2 seconds while supporting real-time imaging during minimally invasive procedures.

Report Coverage of Fluoroscopy and Mobile C-arms Market

The Fluoroscopy and Mobile C-arms Market Report provides a comprehensive analysis of imaging technologies used in surgical and diagnostic procedures across hospitals, clinics, and diagnostic centers worldwide. The report evaluates global adoption of fluoroscopy systems used in more than 310 million diagnostic and surgical procedures annually. It examines equipment types including full-size C-arms and mini C-arms used for orthopedic trauma surgeries, cardiovascular interventions, gastrointestinal imaging, and pain management procedures. The Fluoroscopy and Mobile C-arms Industry Analysis covers more than 120 countries with healthcare infrastructure consisting of over 80,000 hospitals and medical institutions performing imaging-guided procedures. The report assesses installation trends across operating rooms, ambulatory surgical centers, and diagnostic imaging facilities. Approximately 70% of surgical suites globally utilize mobile C-arm systems for real-time imaging during minimally invasive procedures.

The Fluoroscopy and Mobile C-arms Market Research Report also evaluates technological advancements in digital imaging systems including flat-panel detectors, three-dimensional cone-beam CT integration, and artificial intelligence-based image processing technologies. Nearly 67% of newly installed fluoroscopy systems utilize digital detector technology delivering image resolution above 3 megapixels. AI imaging algorithms integrated into approximately 39% of systems improve visualization clarity and reduce radiation exposure by nearly 30%. The report analyzes procedure volumes across key medical specialties including orthopedics, cardiology, neurology, and gastrointestinal imaging. Orthopedic procedures alone exceed 28 million annually and frequently require mobile C-arm imaging for fracture fixation and implant placement. Cardiovascular interventions represent more than 8 million procedures annually requiring continuous fluoroscopic guidance.

Fluoroscopy and Mobile C-arms Market Report Coverage

REPORT COVERAGE DETAILS
Market Size Value In USD 2759.42 Million in 2026
Market Size Value By USD 3893.86 Million by 2035
Growth Rate CAGR of 3.9% from 2026 - 2035
Forecast Period 2026 - 2035
Base Year 2025
Historical Data Available Yes
Regional Scope Global
Segments Covered
By Type Full-size C-arms | Mini C-arms
By Application Hospitals | Clinics | Diagnostic Centers

Frequently Asked Questions

The global Fluoroscopy and Mobile C-arms Market is expected to reach USD 3893.86 Million by 2035.

The Fluoroscopy and Mobile C-arms Market is expected to exhibit a CAGR of 3.9% by 2035.

GE Healthcare,Philips Healthcare,Siemens Healthcare,Hitachi, Ltd,Shimadzu,Canon Medical Systems,Ziehm Imaging GmbH,Hologic,Orthoscan Inc,Allengers Medical Systems,EcoRay,Eurocolumbus,Italray,Omega Medical Imaging.

In 2026, the Fluoroscopy and Mobile C-arms Market value stood at USD 2759.42 Million.

OUR
CLIENTS

Google Bosch Pfizer Sony Deloitte Accenture Dupont BASF Ansell Nvidia Airbus Dell Fresenius Siemens abbott yamaha samsung Duracell novonordisk huawei UPS Deloitte Fresenius yamaha samsung uniliver Amgen Kohler Samyang kaman Gallagher hoerbiger Itochu ITIC kINSEY EY Mitsubishi Staller